SMARTease Trial: Evaluating Stroke Help Distance Interventions to Improve Cognitive Performance Post-Stroke

Sponsor
Nova Scotia Health Authority (Other)
Overall Status
Terminated
CT.gov ID
NCT01407081
Collaborator
IWK Health Centre (Other), Canadian Institutes of Health Research (CIHR) (Other)
10
1
1
8
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to provide evidence for the feasibility and initial effectiveness of a manualized, telephone-based (telehealth) approach to the delivery of cognitive interventions (SMARTease) targeted to improve cognitive performance in daily activities after stroke.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Telerehabilitation Cognitive Strategy Training
Phase 3

Detailed Description

An initial brief screening interview will be completed with the potential participant by telephone to determine whether or not the individual meets the criteria for the study.

In an initial onsite visit, informed consent will be obtained from both the stroke survivor and their study partner and baseline evaluations will be completed with the stroke survivor, including a baseline cognitive assessment and setting goals to work on during the study period. Then the introductory section of the study Handbook (Making the Most of Your Memory) which includes procedural information on the Stroke Help Program will be reviewed with the stroke survivor and study partner. A study Handbook and a large button speaker phone will be provided to the stroke survivor/partner pair to ensure that both members of the participant-caregiver team can listen to the rehabilitation coach without having to be concerned with holding a handset (an action that may be difficult for some stroke survivors).

Telephone contact by the rehabilitation coach will be organized and the 16-week Stroke Help Cognitive Strategy Training Intervention will proceed. In general the topics or strategies to be discussed will be used to achieve one or more of the following rehabilitation strategies:

  1. Understanding cognitive deficits that may result from stroke; 2). Reinforcing, strengthening or re-establishing previously learned patterns of behavior; 3) Establishing new patterns of compensatory mechanisms; 4) Enabling persons to adapt to their cognitive disability.

Following the 16-week Cognitive Strategy Training Intervention participants will have an on-site visit to provide qualitative and quantitative data related to the feasibility and efficacy of the program.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
SMARTease Trial - Turning SMART Goals Into Smart Actions: Evaluating Stroke Help Distance Interventions to Improve Cognitive Performance Post-Stroke
Study Start Date :
Aug 1, 2011
Actual Primary Completion Date :
Apr 1, 2012
Actual Study Completion Date :
Apr 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Training

telerehabilitation cognitive strategy training

Behavioral: Telerehabilitation Cognitive Strategy Training
The strategy intervention is a 16-week program during which a trained rehabilitation coach speaks by telephone to the stroke participant and their caregiver twice a week (one approximately 45-minute 'training' call and one approximately 15-minute 'update' call). Rehabilitation discussions during the training calls will follow a detailed protocol and focus each week on the stroke education and cognitive strategy training information provided in each section of the manual provided to the participants.
Other Names:
  • cognitive rehabilitation
  • Outcome Measures

    Primary Outcome Measures

    1. Change in functioning [Measured at baseline and week 18]

      estimating within subject effect sizes for the treated group based on changes in measures at the level of impairment (self and other-reported cognitive performance), activity (achievement of activity goals and everyday cognitive performance) and participation/quality of life (self-report measures of reintegration to normal living, quality of life, caregiver burden).

    Secondary Outcome Measures

    1. Intervention modifiers [measured at baseline and weekly until end of study at week 18]

      Additional secondary analyses will also investigate variables that could modify the effects of the interventions, including cognitive profile, stroke severity and location of lesion, co-morbid conditions, type of functional goal and current environmental factors.

    2. Feasibility [measured at end of 16 week study]

      Feasibility as measured by rates of subject recruitment, retention, and compliance with protocol

    3. Feasibility-Coach adherence [measured at weekly intervals]

      Feasibility of coach adherence to therapy protocols will be assessed weekly through review of adherence to scripts and completeness of data collection

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • history of one or more strokes;

    • living in the community;

    • subjective concerns about cognitive function;

    • ability to give informed consent;

    • fluent in written and spoken English.

    Exclusion Criteria:
    • unstable medical conditions or a co-morbid neurological disorder that could additionally impact cognitive or daily function, such as Parkinson's disease or Multiple Sclerosis;

    • no available caregiver or significant other willing to participate in approximately one hour of telephone contact per week with coach and stroke survivor;

    • current symptoms of severe depression (Geriatric Depression Scale>20), global aphasia, or dementia (determined by baseline testing).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Capital District Health Authority Halifax Nova Scotia Canada B3H 1V7

    Sponsors and Collaborators

    • Nova Scotia Health Authority
    • IWK Health Centre
    • Canadian Institutes of Health Research (CIHR)

    Investigators

    • Principal Investigator: Gail A Eskes, Ph.D., Capital District Health Authority, Nova Scotia, Canada

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gail Eskes, Dr. Gail Eskes, Professor, Department of Psychiatry, Nova Scotia Health Authority
    ClinicalTrials.gov Identifier:
    NCT01407081
    Other Study ID Numbers:
    • CDHA-RS/2012-040
    First Posted:
    Aug 1, 2011
    Last Update Posted:
    Aug 1, 2014
    Last Verified:
    Jul 1, 2014
    Keywords provided by Gail Eskes, Dr. Gail Eskes, Professor, Department of Psychiatry, Nova Scotia Health Authority
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 1, 2014